Literature DB >> 10670571

Distribution and expression of bca, the gene encoding the c alpha protein, by Streptococcus agalactiae.

J A Maeland, O G Brakstad1, L Bevanger, S Krokstad.   

Abstract

A total of 52 clinical isolates of group B streptococci (GBS) was tested for expression of the c protein c(alpha) by a fluorescent antibody test (FAT) and by PCR amplification of a 202-bp stretch within the repeat unit of the bca gene encoding the c(alpha) protein. The strains were categorised as follows: c(alpha) FAT positive and PCR positive with amplification products of multiple sizes (category A, n = 12); FAT negative and with PCR products of multiple sizes (category B, n = 11); FAT negative and with a single PCR product of c. 200 bp (category C, n = 5); negative in both tests (category D, n = 24). A single amplification product of minimum size and additional products of larger sizes corresponded to one and more bca repeats, respectively. Five of the 11 category B strains showed expression of low Mr c(alpha) in whole cell-based Western blotting. The results showed that a proportion of the GBS isolates harboured bca gene elements that either were not expressed or they expressed c(alpha) molecular variants which could not be detected by the whole cell-based FAT. This genotype/phenotype discrepancy should be considered in relation to GBS typing, including the selection of antibody reagents and the technical approach to c(alpha) protein detection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10670571     DOI: 10.1099/0022-1317-49-2-193

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

1.  Immunological markers of the R4 protein of Streptococcus agalactiae.

Authors:  Johan A Maeland; Lars Bevanger; Randi Valsoe Lyng
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

2.  Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes.

Authors:  Fanrong Kong; Sonia Gowan; Diana Martin; Gregory James; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  bca, beta gene, and gene product divergency in reference and prototype strains of streptococcus agalactiae.

Authors:  J A Maeland; L Bevanger; G Iversen; R V Lyng
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Antigenic determinants of alpha-like proteins of Streptococcus agalactiae.

Authors:  Johan A Maeland; Lars Bevanger; Randi Valsoe Lyng
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

5.  Distinctive features of surface-anchored proteins of Streptococcus agalactiae strains from Zimbabwe revealed by PCR and dot blotting.

Authors:  Rooyen T Mavenyengwa; Johan A Maeland; Sylvester R Moyo
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

6.  The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates.

Authors:  Shannon D Manning; Moran Ki; Carl F Marrs; Kiersten J Kugeler; Stephanie M Borchardt; Carol J Baker; Betsy Foxman
Journal:  BMC Infect Dis       Date:  2006-07-17       Impact factor: 3.090

7.  Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing Streptococcus agalactiae (group B streptococcus) from Malaysian patients.

Authors:  N Eskandarian; Z Ismail; V Neela; A van Belkum; M N M Desa; S Amin Nordin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-31       Impact factor: 3.267

8.  Analysis of virulence factors and antibiotic resistance genes in group B streptococcus from clinical samples.

Authors:  Raymond Mudzana; Rooyen T Mavenyengwa; Muchaneta Gudza-Mugabe
Journal:  BMC Infect Dis       Date:  2021-01-28       Impact factor: 3.090

9.  Epidemiology of and prenatal molecular distinction between invasive and colonizing group B streptococci in The Netherlands and Taiwan.

Authors:  E van Elzakker; R Yahiaoui; C Visser; P Oostvogel; A Muller; Y-R Ho; J-J Wu; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-03-31       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.